Last month, 2 Scientific Business Consultants from Genedata had the opportunity to speak at Bio Japan 2022, one of the world’s most long-standing biotechnology exhibitions, held on Oct 12-14 at PACIFICO Yokohama, Japan. Despite the cold weather, we saw many leaders from the industry get together to have significant discussions on novel biotherapeutics and solutions enabling innovation.
Genedata transforms data into intelligence with innovative software solutions that incorporate extensive biopharma R&D domain knowledge. Multinational biopharmaceutical organizations and cutting-edge biotechs around the globe rely on Genedata to digitalize and automate data-rich and complex R&D processes. From early discovery all the way to the clinic, Genedata solutions help maximize the ROI in R&D expenditure.
This time at the Bio Japan conference, we were invited to present at two seminars;
“Digital Innovation in Next-generation Biopharmaceutical Manufacturing” Moderator: Prof. Kazuhisa Uchida (Kobe University)
“The Last Bastion in the Supply Chain - Biotech Human Resource Development - From Technology Transfer, AI/DX Human Resources to Dual-Use Technology” Moderator: Prof. Takeshi Omasa (Osaka University)
Digital Innovation in Next-generation Biopharmaceutical Manufacturing
The day started with a seminar hosted by Prof. Uchida, discussing the future direction of production processes, including productivity improvement, process efficiency, and reducing risks in manufacturing, for new modalities that are being developed as next-generation biopharmaceuticals and vaccines.
Mizue Hisano Ph.D., Genedata Scientific Business Consultant, introduced Genedata Bioprocess as a solution for digitalizing biopharmaceutical manufacturing processes in a presentation titled "Digitalization of Bioprocess Development - Introduction to Genedata Bioprocess". Genedata Bioprocess® designs next-generation bio-manufacturing processes across CLD, USP and DSP, formulation, and analytics development. It enforces data integrity and compliance, streamlining development of originator drugs and biosimilars.
During the panel discussion with Mr. Satish Singh (Moderna Therapeutics), Prof. Tomohisa Hasunuma (Kobe University), and Dr. Shin Kawamata (Foundation for Biomedical Research and Innovation at Kobe), each panelist shared their opinion on topics such as cloud or on premise software hosting, in-house or outsourcing IT resources, and strategies for facilitating digitalization. Mizue mentioned how Genedata solutions have the flexibility for customers to choose between cloud and on premise implementation, and how we work closely with the IT team as well as the scientists in optimizing our software deployment and ongoing usage.
Biotech Human Resource Development - From Technology Transfer, AI/DX Human Resources to Dual-Use Technology
In the afternoon, Genedata participated in another seminar, this one discussing biotech human resource nurturing - from technology transfer to latest applications such as AI, digital transformation, and dual-use technology.
Shunya Kondo Ph.D., Genedata Scientific Business Consultant for Genedata Profiler, gave a talk on the skills needed to digitalize biopharma R&D, based on career paths taken by Scientific Account Managers and his current experience working in Basel, Switzerland. Genedata software solutions are used by more than 200 organizations worldwide, including all of the top 25 pharmaceutical companies in the world. People at Genedata combine scientific curiosity with a passion for accelerating the pace of biopharma R&D. The culture at Genedata fosters respect and integrity and team members have scientific, business, technical expertise, and work on challenging topics every day.
The panelists for this session were Prof. Takashi Suzuki (Osaka University), Mr. Tomoyuki Fujisawa (Axcelead, Inc./ARCALIS, Inc.), Prof. Hisakazu Matsushige (Osaka University), and Prof. Norichika Ogata (Nihon BioData Corp.). Discussion topics included university education, job requirements, working environment, and career paths for highly skilled professionals in the biotechnology field. Shunya shared his opinion on working in Switzerland as a Japanese, and how Genedata values people who are passionate about science as well as supporting the development of novel biotherapeutics.
Genedata will continue to provide information on digitalizing biopharma R&D.